DOI 10.1080/07853890.2025.2575108
Impact of diabetes and glycemic control during cancer care on mortality in non-metastatic solid and hematologic malignancies.
Аннотация
BACKGROUND
Whether cancer patients with diabetes can achieve survival outcomes comparable to those without diabetes through appropriate glycemic control over the course of cancer remains uncertain.
AIM: To assess mortality risk among cancer patients with diabetes compared to those without diabetes, and to evaluate whether this risk differed by level and pattern of visit-to-visit glycemic control.
MATERIALS AND
METHODS
We conducted a retrospective cohort study using electronic health records from a tertiary cancer center. Adults with non-metastatic solid or hematologic malignancies and a history of diabetes, treated between 2009 and 2021, were individually matched in a 1:2 ratio to cancer patients without diabetes based on cancer type, sex, age, and treatment year, and were followed through June 2024. Mortality risks were assessed, accounting for cancer stage, aggressiveness, comorbidities, BMI, and cancer and diabetes treatments.
RESULTS
Among 29,812 patients, 1948 (650 with diabetes and 1298 without) were eligible, with a total follow-up of 112,809 patient-months. Mortality risk among patients with diabetes was similar to those without (adjusted HR, 1.11 [0.89-1.39]; p = 0.35). Compared to those without diabetes, patients with good or fair glycemic control (average glucose ≤180 mg/dL) had no increased mortality risk (adjusted HR, 0.96 [0.75-1.23]; p = 0.76), while those with poor control had significantly higher risk (adjusted HR, 1.68 [1.12-2.53]; p = 0.012). Patients who experienced severe hypoglycemia had higher mortality than those without hypoglycemia (adjusted HR, 2.31 [1.01-5.28]; p = 0.048). Greater visit-to-visit glucose variability was also associated with increased mortality (adjusted HR, 1.02 [1.00-1.04]; p = 0.018).
CONCLUSIONS
Overall, the mortality risk among patients with cancer and diabetes was comparable to those without diabetes. However, among those with diabetes, poor glycemic control, hypoglycemia, and high glycemic variability were associated with worse survival-highlighting the need for integrated, chronic disease-informed cancer care strategies to improve patient outcomes.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.